Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03884972
Title Trabectedin and Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Resistant or Intolerant to a BTK Inhibitor
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors M.D. Anderson Cancer Center

chronic lymphocytic leukemia/small lymphocytic lymphoma


Trabectedin + Venetoclax

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.